期刊文献+

药物涂层球囊治疗股腘动脉硬化闭塞症的临床疗效及安全性 预览 被引量:5

Effect and safety of drug-coated balloon for treating femoropopliteal arteriosclerosis obliterans
在线阅读 下载PDF
收藏 分享 导出
摘要 目的 探讨药物涂层球囊(DCB)治疗股腘动脉硬化闭塞症的有效性及安全性。方法 经预扩张筛选后,将拟接受经皮腔内血管成形术(PTA)的54例股腘动脉硬化闭塞症患者随机分为试验组(n=27)及对照组(n=27),PTA术中分别采用DCB及普通球囊。PTA术后随访6个月,比较2组疗效及安全性,并对术中出现的非限流性夹层患者进行对比分析。结果 剔除失访者后,最终试验组26例、对照组20例患者纳入研究。试验组术后6个月踝肱指数(ABI)、股腘动脉最小管腔直径(MLD)均高于对照组(P均〈0.05);Rutherford分级、股腘动脉狭窄程度、晚期管腔丢失(LLL)值、再狭窄率及靶病变血运重建(TLR)发生率均低于对照组(P均〈0.05)。试验组及对照组出现非限流性夹层的患者分别为14例及8例;2组出现非限流性夹层的患者间术后6个月ABI、Rutherford分级差异均无统计学意义(P均〉0.05),其余各疗效评价指标差异均有统计学意义(P均〈0.05)。2组间主要不良事件发生率及截肢率差异均无统计学意义(P均〉0.05)。结论 DCB治疗股腘动脉硬化闭塞症的近期疗效优于普通球囊,且二者安全性相似;对于PTA术中出现非限流性夹层患者,DCB疗效仍优于普通球囊。 Objective To evaluate the effect and safety of drug-coated balloon (DCB) for treating femoropopliteal arteriosclerosis obliterans. Methods Totally 54 patients with femoropopliteal arteriosclerosis obliterans who underwent percutaneous transluminal angioplasty (PTA) were randomly divided into test group and control group after successful predilation during operation. Patients in test group were treated with DCB, while those in control group were treated with uncoated balloon (UCB) during PTA. A 6-month follow-up was performed after operation. The treatment effect and safety between the two groups were compared. Additional analysis among patients who had a non-flow-limiting dissection during PTA in each group was done.Results Six months after PTA, there were 26 patients in test group and 20 patients in control group after getting rid of 8 patients lost to follow-up. The ankle brachial index (ABI) and minimal lumen diameter (MLD) of target lesion were higher (both P〈0.05), and the Rutherford stage, degree of target lesion stenosis, late lumen lose (LLL), the rate of restenosis and target lesion revascularization (TLR) were lower (all P〈0.05) in test group than those in control group. There were 14 patients in test group (subgroup A) and 8 patients in control group (subgroup B) who had a non-flow-limiting dissection. Except for the ABI and Rutherford stage 6 months after PTA (both P〉0.05), the other effect indexes were statistically different between the two subgroups (all P〈0.05). The rates of major adverse events and amputation were similar between test group and control group (both P〉0.05). Conclusion DCB has better short-term effect than UCB for treating femoropopliteal arteriosclerosis obliterans as safe as UCB. Meanwhile, DCB is better than UCB in patients with a non-flow-limiting dissection during PTA.
作者 陈旭姣 畅智慧 刘兆玉 CHEN Xujiao , CHANG Zhihui , LIU Zhaoyu (Department of Radiology, Shengj ing Hospital of China Medical University, Shen yang 110004, China)
出处 《中国介入影像与治疗学》 CSCD 北大核心 2018年第3期139-143,共5页 Chinese Journal of Interventional Imaging and Therapy
关键词 下肢 动脉硬化 闭塞性 股动脉 腘动脉 药物涂层球囊 治疗结果 安全性 Lower extremity Arteriosclerosis obliterans Femoral artery Popliteal artery Drug-coated ballon Treatment outcome Safety
作者简介 陈旭姣(1990-),女,山东济宁人,在读硕士。研究方向:药物涂层球囊在股腘动脉硬化性病变中的应用。E—mail:1464753732@qq.com;[通信作者]刘兆玉,中国医科大学附属盛京医院放射科,110004。E—mail:liuzy@sj—hospital.Org
  • 相关文献

参考文献1

二级参考文献11

  • 1谷涌泉,张建,齐立行,李建新,俞恒锡,李学锋,郭连瑞,崔世军,汪忠镐.下肢动脉支架与单纯球囊扩张成形治疗股浅动脉病变的对比性研究[J].中国血管外科杂志(电子版),2010(2):83-86. 被引量:1
  • 2Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angio- plasty in severe ischaemia of the leg (BASIL) : Multicentre, randomised controlled trial. Lancet, 2005,366(9501) : 1925-1934. 被引量:1
  • 3Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society con- sensus for the management of peripheral arterial disease (TASC 11 ). J Vasc Surg, 2007,45(Suppl S) :S5-S67. 被引量:1
  • 4Siracuse JJ, Giles KA, Pomposelli FB, et al. Results for primary bypass versus primary angioplasty/stent for intermittent claudica- tion due to superficial femoral artery occlusive disease. J Vasc Surg, 2012,55(4) :1001-1007. 被引量:1
  • 5Bradbury AW, Adam DJ, Bell J, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients ran- domized to a bypass surgery-first or a balloon angioplasty-first re vascularization strategy. J Vasc Surgery, 2010,51(5 Suppl) : 5S- 17S. 被引量:1
  • 6Mutirangura P, Ruangsetakit C, Wongwanit C, et al. Compara- tive study of the management of diabetic versus nondiabetic pa- tients with atherosclerosis obliterans of the lower extremities. Vascular, 2008,16(6) :333-339. 被引量:1
  • 7Suzuki T, Sato Y, Niizuma S, et al. Efficacy of low-density lip- oprotein apheresis in arteriosclerosis obliterans of the lower ex- tremities: Two cases with marked alleviation of clinical symp- toms. J Clin Apher, 2007,22(5) :287-291. 被引量:1
  • 8陈忠.动脉硬化闭塞症下肢缺血治疗方案的选择[J].临床外科杂志,2008,16(5):296-298. 被引量:13
  • 9刘昌伟,.下肢动脉硬化性闭塞症治疗指南[J].中国实用外科杂志,2008,28(11):923-924. 被引量:100
  • 10张希全,凌宝存,朱伟,潘晓琳,董戈,郭锋,袁磊.经皮血管内支架成形术治疗下肢动脉硬化性闭塞疾病[J].中国介入影像与治疗学,2009(4):334-337. 被引量:10

共引文献15

同被引文献34

引证文献5

二级引证文献1

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈